Why the study?
Does the concomitant presence of NAFLD and systemic inflammation increase the risk of developing coronary artery calcification?
Population
Subjects with non-alcoholic fatty liver disease (NAFLD) and systemic inflammation
Design
Cohort
Follow-up
four years
Authors
Loading...
May support CAC risk stratification incorporating NAFLD and hs-CRP; leaves open whether targeted interventions alter progression.
Does the concomitant presence of NAFLD and systemic inflammation increase the risk of developing coronary artery calcification?
The combination of NAFLD and systemic inflammation identifies patients at increased risk for developing coronary artery calcification over a four-year period.
Kim et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: